Longing to act: Bayesian inference as a framework for craving in behavioral addiction.

Bayesian inference Behavioral addiction Craving Dopamine Interoception Prior beliefs Reward Substance use disorder

Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 10 2022
revised: 08 05 2023
accepted: 10 05 2023
pmc-release: 01 09 2024
medline: 12 6 2023
pubmed: 19 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

Traditionally, craving is considered a defining feature of drug addiction. Accumulating evidence suggests that craving can also exist in behavioral addictions (e.g., gambling disorder) without drug-induced effects. However, the degree to which mechanisms of craving overlap between classic substance use disorders and behavioral addictions remains unclear. There is, therefore, an urgent need to develop an overarching theory of craving that conceptually integrates findings across behavioral and drug addictions. In this review, we will first synthesize existing theories and empirical findings related to craving in both drug-dependent and -independent addictive disorders. Building on the Bayesian brain hypothesis and previous work on interoceptive inference, we will then propose a computational theory for craving in behavioral addiction, where the target of craving is execution of an action (e.g., gambling) rather than a drug. Specifically, we conceptualize craving in behavioral addiction as a subjective belief about physiological states of the body associated with action completion and is updated based on both a prior belief ("I need to act to feel good") and sensory evidence ("I cannot act"). We conclude by briefly discussing the therapeutic implications of this framework. In summary, this unified Bayesian computational framework for craving generalizes across addictive disorders, provides explanatory power for ostensibly conflicting empirical findings, and generates strong hypotheses for future empirical studies. The disambiguation of the computational components underlying domain-general craving using this framework will lead to a deeper understanding of, and effective treatment targets for, behavioral and drug addictions.

Identifiants

pubmed: 37201396
pii: S0306-4603(23)00147-8
doi: 10.1016/j.addbeh.2023.107752
pmc: PMC10330403
mid: NIHMS1902564
pii:
doi:

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107752

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA043695
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA049243
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007280
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Cereb Cortex. 2018 Apr 1;28(4):1282-1296
pubmed: 28334143
Trends Cogn Sci. 2014 Jun;18(6):269-70
pubmed: 24582825
Exp Clin Psychopharmacol. 2002 Feb;10(1):47-53
pubmed: 11871362
Neuropharmacology. 2004;47 Suppl 1:214-26
pubmed: 15464139
JAMA Psychiatry. 2016 Nov 01;73(11):1127-1134
pubmed: 27603142
Trends Cogn Sci. 2009 Sep;13(9):372-80
pubmed: 19716751
Addiction. 2008 Oct;103(10):1678-86
pubmed: 18705688
Front Neurol. 2021 Dec 07;12:753753
pubmed: 34950099
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):30-5
pubmed: 22100353
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6
pubmed: 20679212
J Psychiatry Neurosci. 2016 Jul 19;41(5):150358
pubmed: 27434467
Addict Behav. 2004 May;29(3):507-23
pubmed: 15050670
Philos Trans R Soc Lond B Biol Sci. 2016 Nov 19;371(1708):
pubmed: 28080966
Psychopharmacology (Berl). 2019 Aug;236(8):2405-2412
pubmed: 31230144
Exp Clin Psychopharmacol. 2011 Apr;19(2):105-15
pubmed: 21463067
Neuropsychopharmacology. 2006 Dec;31(12):2728-38
pubmed: 16598192
Addiction. 2016 Nov;111(11):1923-1934
pubmed: 27239052
World Neurosurg. 2013 Sep-Oct;80(3-4):S28.e21-31
pubmed: 22824557
Cereb Cortex. 2015 Oct;25(10):3434-45
pubmed: 25056572
J Addict Dis. 2018 Jan-Jun;37(1-2):5-13
pubmed: 29565776
Philos Trans R Soc Lond B Biol Sci. 2014 Nov 5;369(1655):
pubmed: 25267823
Exp Clin Psychopharmacol. 2007 Feb;15(1):93-101
pubmed: 17295588
Arch Gen Psychiatry. 1986 Feb;43(2):107-13
pubmed: 3947206
Ann N Y Acad Sci. 2012 Feb;1248:1-17
pubmed: 22172057
J Med Imaging (Bellingham). 2016 Apr;3(2):023502
pubmed: 27175376
J Addict Dis. 2021 Apr-Jun;39(2):257-264
pubmed: 33305702
Neurosci Biobehav Rev. 2018 Jul;90:174-183
pubmed: 29694845
Biol Psychiatry. 2019 Jun 1;85(11):936-945
pubmed: 30737015
Addiction. 2010 Jan;105(1):49-55
pubmed: 20078462
Brain. 2010 May;133(Pt 5):1484-93
pubmed: 20395264
Nat Rev Neurosci. 2010 Feb;11(2):127-38
pubmed: 20068583
Trends Neurosci. 2004 Dec;27(12):712-9
pubmed: 15541511
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2539-44
pubmed: 25605923
J Psychopharmacol. 1998;12(1):23-30
pubmed: 9584965
Neuropsychopharmacology. 2020 Jan;45(2):256-265
pubmed: 31422417
Subst Abuse Rehabil. 2016 Mar 17;7:3-13
pubmed: 27051333
Nature. 2001 Jul 12;412(6843):141-2
pubmed: 11449260
Transl Psychiatry. 2017 Jan 3;7(1):e992
pubmed: 28045460
Science. 2004 Aug 13;305(5686):1017-9
pubmed: 15310907
Neuropsychopharmacology. 2018 Nov;43(12):2337-2339
pubmed: 29930384
Curr Opin Neurobiol. 2015 Feb;30:66-72
pubmed: 25262209
Nat Rev Neurosci. 2015 Jul;16(7):419-29
pubmed: 26016744
Addict Behav. 2014 Oct;39(10):1533-6
pubmed: 24980287
Mol Psychiatry. 2015 Mar;20(3):345-52
pubmed: 24840709
Nature. 2008 Jul 3;454(7200):118-21
pubmed: 18500330
Alcohol Res Health. 2011;33(4):380-8
pubmed: 23580022
Am J Drug Alcohol Abuse. 2010 Sep;36(5):233-41
pubmed: 20560821
Eur J Neurosci. 2011 Apr;33(7):1318-26
pubmed: 21261758
Nat Neurosci. 2005 Nov;8(11):1481-9
pubmed: 16251991
Front Psychiatry. 2013 May 30;4:47
pubmed: 23750138
J Comp Neurol. 2013 Oct 15;521(15):3371-88
pubmed: 23749500
Biol Psychiatry. 2011 Apr 1;69(7):708-11
pubmed: 20817135
PLoS One. 2016 Jun 28;11(6):e0158323
pubmed: 27352037
Tob Control. 2010 Oct;19(5):410-6
pubmed: 20675688
Drug Alcohol Depend. 2010 Dec 1;112(3):220-5
pubmed: 20729009
eNeuro. 2018 Oct 10;5(4):
pubmed: 30310863
JAMA Psychiatry. 2017 Apr 1;74(4):419-420
pubmed: 28199454
Front Comput Neurosci. 2015 Nov 04;9:136
pubmed: 26581305
Cogn Affect Behav Neurosci. 2015 Sep;15(3):523-36
pubmed: 25801925
Alcohol Clin Exp Res. 2015 Feb;39(2):343-9
pubmed: 25684053
J Subst Abuse Treat. 2022 Jul;138:108749
pubmed: 35216868
Noro Psikiyatr Ars. 2016 Mar;53(1):17-22
pubmed: 28360760

Auteurs

Kaustubh R Kulkarni (KR)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Madeline O'Brien (M)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Xiaosi Gu (X)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: xiaosi.gu@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH